Abstract
It is critical to set up an efficient maturation method to increase the yield of mature oocytes, especially for cancer patients with fewer chances of fertility preservation (FP) before gonadotoxic therapy. The purpose of this study is to investigate whether dual triggering with human chorionic gonadotropin (hCG) and gonadotropin-releasing hormone agonist (GnRHa) for final oocyte maturation improve the controlled ovarian stimulation (COS) outcomes for women undergoing FP.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
